Huda, Ahsan
CastaƱo, Adam
Niyogi, Anindita
Schumacher, Jennifer
Stewart, Michelle
Bruno, Marianna
Hu, Mo
Ahmad, Faraz S.
Deo, Rahul C. http://orcid.org/0000-0002-2791-9434
Shah, Sanjiv J. http://orcid.org/0000-0002-5655-8201
Funding for this research was provided by:
Pfizer
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL140731, R01 HL127028, R01 HL107577)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Article History
Received: 5 June 2020
Accepted: 31 March 2021
First Online: 11 May 2021
Competing interests
: S.J.S. has received grants from Actelion, AstraZeneca, Corvia, Novartis, and Pfizer; and has received consulting fees from Actelion, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Cardiora, Eisai, Ionis, Ironwood, Merck, Novartis, Pfizer, Sanofi, and United Therapeutics. R.C.D. has received a grant from GE Healthcare and has received consulting fees from Novartis and Pfizer. A.C., M.B., A.H., A.N., M.S., and J.S. are full-time employees of Pfizer. All other authors report no competing interests.